NO177127C - Fremgangsmåte for fremstilling av aspiringranuler med regulert frigjöringseffekt - Google Patents

Fremgangsmåte for fremstilling av aspiringranuler med regulert frigjöringseffekt

Info

Publication number
NO177127C
NO177127C NO900009A NO900009A NO177127C NO 177127 C NO177127 C NO 177127C NO 900009 A NO900009 A NO 900009A NO 900009 A NO900009 A NO 900009A NO 177127 C NO177127 C NO 177127C
Authority
NO
Norway
Prior art keywords
aspirated
granules
preparing
controlled release
release effect
Prior art date
Application number
NO900009A
Other languages
English (en)
Norwegian (no)
Other versions
NO900009D0 (no
NO177127B (no
NO900009L (no
Inventor
Steven Edgar Frisbee
William Neil Charman
Garret Adare Fitzgerald
Original Assignee
Sterling Winthrop Inc
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/293,832 external-priority patent/US4970081A/en
Application filed by Sterling Winthrop Inc, Sterling Drug Inc filed Critical Sterling Winthrop Inc
Publication of NO900009D0 publication Critical patent/NO900009D0/no
Publication of NO900009L publication Critical patent/NO900009L/no
Publication of NO177127B publication Critical patent/NO177127B/no
Publication of NO177127C publication Critical patent/NO177127C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO900009A 1989-01-03 1990-01-02 Fremgangsmåte for fremstilling av aspiringranuler med regulert frigjöringseffekt NO177127C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/293,832 US4970081A (en) 1989-01-03 1989-01-03 Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
US42662089A 1989-10-24 1989-10-24

Publications (4)

Publication Number Publication Date
NO900009D0 NO900009D0 (no) 1990-01-02
NO900009L NO900009L (no) 1990-07-04
NO177127B NO177127B (no) 1995-04-18
NO177127C true NO177127C (no) 1995-07-26

Family

ID=26968181

Family Applications (1)

Application Number Title Priority Date Filing Date
NO900009A NO177127C (no) 1989-01-03 1990-01-02 Fremgangsmåte for fremstilling av aspiringranuler med regulert frigjöringseffekt

Country Status (20)

Country Link
EP (1) EP0377439B1 (de)
JP (1) JP2966871B2 (de)
KR (1) KR0151590B1 (de)
AR (1) AR244548A1 (de)
AT (1) ATE127690T1 (de)
AU (1) AU622254B2 (de)
CA (1) CA2006975C (de)
DE (1) DE69022251T2 (de)
DK (1) DK0377439T3 (de)
ES (1) ES2076975T3 (de)
FI (1) FI95776C (de)
GR (1) GR3017576T3 (de)
HK (1) HK35396A (de)
IE (1) IE69270B1 (de)
IL (1) IL92854A (de)
MX (1) MX174376B (de)
MY (1) MY104871A (de)
NO (1) NO177127C (de)
NZ (1) NZ231954A (de)
PT (1) PT92780B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
PL337813A1 (en) * 1997-06-11 2000-09-11 Procter & Gamble Coated tablet with a coating ensuring safe administration for upper portion of the gastrointestinal tract
MX2007008162A (es) * 2005-01-06 2007-07-24 Cv Therapeutics Inc Formulaciones farmaceuticas de liberacion prolongada que contienen ranolazina.
WO2008140459A1 (en) * 2007-05-16 2008-11-20 Fmc Corporation Solid form
KR101109633B1 (ko) * 2007-08-03 2012-01-31 제이더블유중외제약 주식회사 활성성분의 코팅막이 보호되는 구강내붕해제형을 제조하기위한 조성물
CR20180209A (es) * 2015-10-09 2018-08-09 Bayer Healthcare Llc Formulación de liberación modificada de naproxeno sodico
US11253484B2 (en) * 2018-01-30 2022-02-22 Nitto Denko Corporation Transdermal absorption preparation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0064485B1 (de) * 1981-04-27 1985-07-24 Aktiebolaget Hässle Pharmazeutisches Präparat
GB8519310D0 (en) * 1985-07-31 1985-09-04 Zyma Sa Granular active substances
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
NZ228557A (en) * 1988-04-05 1990-11-27 Kyowa Hakko Kogyo Kk Coating agent for delaying the release of active agents to be administered per os to ruminants, and veterinary compositions
US4866046A (en) * 1988-05-31 1989-09-12 Top Laboratories, Inc. Low-dosage sublingual aspirin

Also Published As

Publication number Publication date
JP2966871B2 (ja) 1999-10-25
NO900009D0 (no) 1990-01-02
FI900017A0 (fi) 1990-01-03
CA2006975C (en) 2000-04-04
EP0377439A3 (de) 1991-02-06
AU622254B2 (en) 1992-04-02
AR244548A1 (es) 1993-11-30
EP0377439B1 (de) 1995-09-13
MX174376B (es) 1994-05-11
CA2006975A1 (en) 1990-07-03
MY104871A (en) 1994-06-30
GR3017576T3 (en) 1995-12-31
NO177127B (no) 1995-04-18
IL92854A (en) 1994-11-28
DE69022251T2 (de) 1996-05-02
JPH02262520A (ja) 1990-10-25
FI95776C (fi) 1996-03-25
MX18883A (es) 1993-09-01
IL92854A0 (en) 1990-09-17
NZ231954A (en) 1991-12-23
PT92780B (pt) 1997-12-31
IE894120L (en) 1990-07-03
IE69270B1 (en) 1996-08-21
FI900017L (fi) 1990-07-04
DK0377439T3 (da) 1995-10-30
PT92780A (pt) 1990-07-31
ES2076975T3 (es) 1995-11-16
KR900011453A (ko) 1990-08-01
AU4719489A (en) 1990-07-12
ATE127690T1 (de) 1995-09-15
KR0151590B1 (ko) 1998-10-15
DE69022251D1 (de) 1995-10-19
FI95776B (fi) 1995-12-15
HK35396A (en) 1996-03-08
NO900009L (no) 1990-07-04
EP0377439A2 (de) 1990-07-11

Similar Documents

Publication Publication Date Title
NO176758C (no) Analogifremgangsmåte for fremstilling av terapeutiske anvendbare tetrazolyl-bifenylylmetyl-pyrimidiner
FI914174A7 (fi) Menetelmä piperidyylialkyyliamiinien valmistamiseksi
EP0430881A3 (en) Photochromic compounds, process for their preparation and their use
EP0427062A3 (en) Process for the production of methyl formiate
GB9014724D0 (en) Process for the preparation of alpha,beta-olefinically unsaturated compounds
FI903752A7 (fi) Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi
ZA894302B (en) Process for the preparation of granules
FI91961C (fi) Menetelmä (S)- -etyyli-2-okso-1-pyrrolidiiniasetamidin valmistamiseksi
FI902316A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia substituoituja dihydropyrrolitsiiniyhdisteitä
FI890186A7 (fi) Menetelmä 1-hydroksialkyyli-5-nitroimidatsolien valmistamiseksi
CS5891A3 (en) Process for preparing granules with controlled release
FI890185A7 (fi) Menetelmä 1-alkyyli-5-nitroimidatsolien valmistamiseksi
FR2626883B1 (fr) Procede de preparation de n-phosphonomethyl-imino-diacetique
FI890188A7 (fi) Menetelmä 1-hydroksialkyyli-2-metyyli-5-nitroimidatsolien valmistamiseksi
FI913464A7 (fi) Menetelmä 1-hydroksimetyylipyratsolien valmistamiseksi
EP0393350A3 (en) Process for the preparation of amines
FR2643902B1 (fr) Procede de preparation de n-allylmetatrifluoromethylaniline
FI902590A7 (fi) Menetelmä 2-oksoindoli-1-karboksamidien valmistamiseksi
FI902002A7 (fi) Menetelmä kinatsoliinijohdannaisten valmistamiseksi
FI911402A7 (fi) Menetelmä metyylikinoliinijohdannaisten valmistamiseksi
FI901358A0 (fi) Menetelmä fluorifenolien valmistamiseksi
FI923866A7 (fi) Menetelmä 1-hydroksialkyyli-5-nitroimidatsolien valmistamiseksi
EP0434376A3 (en) Ivermectin derivative compounds and process for preparing the same
FI905992L (fi) Menetelmä metyleeni-pristinamysiini-IA- tai metyleeni-virginiamysiinijohdannaisten valmistamiseksi
FI93363C (fi) Uusi menetelmä 2-diatso-3-trisubstituoitujen silyylioksi-3-butenoaattien valmistamiseksi

Legal Events

Date Code Title Description
MK1K Patent expired